Director Dealing

RNS Number : 2913D

Advanced Oncotherapy PLC

26 April 2013

 

26   April 2013

ADVANCED ONCOTHERAPY Plc

("Advanced Oncotherapy" or "the Company")

Director Dealing

Advanced Oncotherapy (AIM: AVO) announces that on 25 April 2013, Michael Sinclair, Chief Executive Officer, purchased 8,250,000 ordinary shares of 1 pence each in the share capital of the Company ("Ordinary Shares") at an average price of 1.655 pence per share.

Following this purchase, Michael Sinclair now holds 69,355,121 Ordinary Shares, representing approximately 26.7 per cent. of the issued share capital of Advanced Oncotherapy.      

For further information, please visit www.advancedoncotherapy.comor contact:

Michael Sinclair, Chief Executive	Sandy Jamieson	Jon Levinson	Simon Hudson
Advanced Oncotherapy Plc	Libertas Capital Corporate Finance Ltd	Peterhouse Corporate Finance	Tavistock Communications
	(NOMAD & Joint Broker)	(Joint Broker)	(Financial PR & IR)
[phone]	[phone]	[phone]	[phone]

 

END

 

 

RDSBIGDSDDDBGXU